| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communication |
From the Department of Medicine, Stanford University School of Medicine, California.
Background: Questions remain as to why postmenopausal women are at a higher risk of coronary artery disease (CAD) than are premenopausal women. Studies have shown that plasma concentrations of remnant lipoproteins (RLPs) are elevated in patients with CAD and that increases in plasma RLP concentrations may be related to variations in insulin-mediated glucose disposal.
Objective: We sought to evaluate the possibility that postprandial accumulation of plasma RLPs will be accentuated in insulin-resistant, postmenopausal women.
Design: Postmenopausal women were divided into insulin-sensitive (n = 15) and insulin-resistant (n = 15) groups according to their steady state plasma glucose concentrations in response to a 180-min infusion of octreotide, insulin, and glucose. Plasma insulin, triacylglycerol, and RLP-cholesterol concentrations were measured either hourly (insulin) or every 2 h (triacylglycerol and RLP cholesterol) for 8 h, before and after breakfast (0800) and lunch (1200).
Results: By selection, insulin-resistant women had higher steady state plasma glucose concentrations than did insulin-sensitive women (10.8 ± 0.5 compared with 4.1 ± 5 mmol/L, respectively; P < 0.001), associated with higher fasting triacylglycerol (1.58 ± 0.04 compared with 1.00 ± 0.03 mmol/L; P = 0.01) and lower HDL-cholesterol (1.06 ± 0.08 compared with 1.34 ± 0.05; P = 0.01) concentrations. In addition, measurements of daylong concentrations of insulin, triacylglycerol, and RLP cholesterol were also significantly greater in insulin-resistant than in insulin-sensitive women (P < 0.001).
Conclusions: Postprandial accumulation of RLPs is accentuated in insulin-resistant, postmenopausal women. This may contribute to the increased risk of CAD in these individuals.
Key Words: Postmenopausal women • remnant lipoproteins • postprandial lipemia • coronary artery disease • CAD • insulin resistance • insulin sensitivity • insulin
This article has been cited by other articles:
|
|
 |
|
  S. Bansal, J. E. Buring, N. Rifai, S. Mora, F. M. Sacks, and P. M Ridker Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women JAMA, July 18, 2007; 298(3): 309 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M Reaven The metabolic syndrome: is this diagnosis necessary? Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1237 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Harbis, S. Perdreau, S. Vincent-Baudry, M. Charbonnier, M.-C. Bernard, D. Raccah, M. Senft, A.-M. Lorec, C. Defoort, H. Portugal, et al. Glycemic and insulinemic meal responses modulate postprandial hepatic and intestinal lipoprotein accumulation in obese, insulin-resistant subjects Am. J. Clinical Nutrition, October 1, 2004; 80(4): 896 - 902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Chu, F. Abbasi, K. R. Kulkarni, C. Lamendola, T. L. McLaughlin, J. N. Scalisi, and G. M. Reaven Multiple Lipoprotein Abnormalities Associated with Insulin Resistance in Healthy Volunteers Are Identified by the Vertical Auto Profile-II Methodology Clin. Chem., June 1, 2003; 49(6): 1014 - 1017. [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Reaven Importance of Identifying the Overweight Patient Who Will Benefit the Most by Losing Weight Ann Intern Med, March 4, 2003; 138(5): 420 - 423. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
